The differential diagnosis of Huntington's diseaselike syndromes: 'Red flags' for the clinician

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 6, 2013, Pages 650-656

  Martino, Davide ^a,b   Stamelou, Maria ^c   Bhatia, Kailash P ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIA; BEHAVIOR DISORDER; BLOOD EXAMINATION; CLINICAL EXAMINATION; CLINICAL FEATURE; COGNITIVE DEFECT; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ETHNICITY; EYE MOVEMENT DISORDER; GAIT DISORDER; HUMAN; HUNTINGTON CHOREA; HUNTINGTON DISEASE LIKE SYNDROME; MEDICAL HISTORY; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SEIZURE;

EID: 84877630721     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-302532     Document Type: Review

References (49)

1. Novak MJ, Tabrizi SJ. Huntington's disease: clinical presentation and treatment. Int Rev Neurobiol 2011;98:297-323.
2. Wild EJ, Mudanohwo EE, Sweeney MG, et al. Huntington's disease phenocopies are clinically and genetically heterogeneous. Mov Disord 2008;23:716-20.
3. Margolis RL, Rudnicki DD, Holmes SE. Huntington's disease like-2: review and update. Acta Neurol Taiwan 2005;14:1-8. (Pubitemid 40515830)
4. Martins S, Madama T, Guimaraes L, et al. Portuguese families with dentatorubropallidoluysian atrophy (DRPLA) share a common haplotype of Asian origin. Eur J Hum Genet 2003;11:808-11. (Pubitemid 37337065)
5. McNeill A, Chinnery PF. Neuroferritinopathy: update on clinical features and pathogenesis. Curr Drug Targets 2012;13:1200-3.
6. Ondo WG, Adam OR, Jankovic J, et al. Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States. Mov Disord 2010;25:2470-2.
7. Juvonen V, Vietala M, Kairisto V, et al. The occurrence of dominant spinocerebellar ataxias among 251 Finnish ataxia patients and the role of predisposing large normal alleles in a genetically isolated population. Acta Neurol Scand 2005;111:154-62. (Pubitemid 40278580)
8. Duquette A, Roddier K, McNabb-Baltar J, et al. Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy. Ann Neurol 2005;57:408-14. (Pubitemid 40343963)
9. Bader B, Walzer RH, Vogel M, et al. Tongue protrusion and feeding dystonia: a hallmark of chorea-acanthocytosis. Mov Disord 2010;25:127-9.
10. Schneider SA, Lang AE, Moro E, et al. Characteristic head drops and axial extension in advanced chorea-acanthocytosis. Mov Disord 2010;25:1487-91.
11. Jung HH, Danek A, Walzer RH. Neuroacanthocytosis syndromes. Orphanet J Rare Dis 2011;6:68.
12. Gantenbein AR, Damon-Perriere N, Bohlender JE, et al. Feeding dystonia in McLeod syndrome. Mov Disord 2011;26:2123-6.
13. Kurian MA, McNeill A, Lin JP, et al. Childhood disorders of neurodegeneration with brain iron accumulation (NBIA). Dev Med Child Neurol 2011;53: 394-404.
14. Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003;348: 33-40. (Pubitemid 36026344)
15. Paisan-Ruiz C, Guevara R, Federoff M, et al. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord 2010;25:1791-800.
16. Dabrowski E, Smathers SA, Raistrom CS, et al. Botulinum toxin as a novel treatment for self-mutilation in Lesch-Nyhan syndrome. Dev Med Child Neurol 2005;47:636-9. (Pubitemid 41195058)
17. Stevanin G, Brice A. Spinocerebellar ataxia 17 (SCA17) and Huntington's disease-like 4 (HDL4). Cerebellum 2008;7:170-8.
18. Tsuji S. Dentatorubral-pallidoluysian atrophy. Handb Clin Neurol 2012;103:587-94.
19. Namekawa M, Takiyama Y, Ando Y, et al. Choreiform movements in spinocerebellar ataxia type 1. J Neurol Sci 2001;187:103-6. (Pubitemid 32611663)
20. Geschwind DH, Perlman S, Figueroa CP, et al. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet 1997;60:842-50. (Pubitemid 27146492)
21. Stevanin G, Hahn V, Lohmann E, et al. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. Arch Neurol 2004;61:1242-8. (Pubitemid 39062678)
22. Koutsis G, Karadima G, Pandraud A, et al. Genetic screening of Greek patients with Huntington's disease phenocopies identifies an SCA8 expansion. J Neurol. Published Online First: 2 February 2012.
23. Zhu D, Burke C, Leslie A, et al. Friedreich's ataxia with chorea and myoclonus caused by a compound heterozygosity for a novel deletion and the trinucleotide GAA expansion. Mov Disord 2002;17:585-9. (Pubitemid 36040975)
24. Spacey SD, Szczygielski BI, Young SP, et al. Malaysian siblings with Friedreich ataxia and chorea: a novel deletion in the frataxin gene. Can J Neurol Sci 2004;31:383-6. (Pubitemid 39295459)
25. Chun HH, Gatti RA. Ataxia-teleangiectasia, en evolvine phenotype. DNA Repair (Amst.) 2004;3:1187-96.
26. Le Ber I, Moreira MC, Rivaud-Pechoux S, et al. Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies. Brain 2003;126:2761-72. (Pubitemid 37463094)
27. Anheim M, Monga B, Fleury M, et al. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain 2009;132:2688-98.
28. Lorincz MT. Neurologic Wilson's disease. Ann N Y Acad Sci 2010;1184:173-87.
29. Schneider SA, Paisan-Ruiz C, Quinn NP, et al. ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Mov Disord 2010;25:979-84.
30. Gradstein L, Danek A, Grafman J, et al. Eye movements in chorea-acanthocytosis. Invest Ophthalmol Vis Sci 2005;46:1979-87.
31. Scheid R, Bader B, Ott DV, et al. Development of mesial temporal lobe epilepsy in chorea-acanthocytosis. Neurology 2009;73:1419-22.
32. Laplanche JL, El Hachimi KH, Durieux I, et al. Prominent psychiatric features and early onset in an inherited prion disease with a new insertional mutation in the prion protein gene. Brain 1999;122:2375-86.
33. McKee D, Talbot P. Chorea as a presenting feature of variant Creutzfeldt-Jakob disease. Mov Disord 2003;18:837-8. (Pubitemid 36939985)
34. Breedveld GJ, van Dongen JWF, Danesino C, et al. Mutations in TITF-1 are associated with benign hereditary chorea. Hum Mol Genet 2002;11:971-9. (Pubitemid 34449784)
35. Kleiner-Fisman G, Calingasan NY, Putt M, et al. Alterations of striatal neurons in benign hereditary chorea. Mov Disord 2005;20:1353-7. (Pubitemid 41645913)
36. Glik A, Vuillaume I, Devos D, et al. Psychosis, short stature in benign hereditary chorea: a novel thyroid transcription factor-1 mutation. Mov Disord 2008;23:1744-7.
37. Armstrong MJ, Shah BB, Chen R, et al. Expanding the phenomenology of benign hereditary chorea: evolution from chorea to myoclonus and dystonia. Mov Disord 2011;26:2296-7.
38. Maccabelli G, Pichiecchio A, Guala A, et al. Advanced magnetic resonance imaging in benign hereditary chorea: study of two familial cases. Mov Disord 2010;25:2670-4.
39. Yoshida Y, Nunomura J, Shimomata T, et al. Benign hereditary chorea 2: pathological findings in an autopsy case. Neuropathology. Published Online First: 12 January 2012. doi:10.1111/j.1440-1789.2011.01288.x
40. Cardoso F, Seppi K, Mair KJ, et al. Seminar on choreas. Lancet Neurol 2006;5:589-602. (Pubitemid 43867433)
41. Koide R, Onondera O, Ikeuchi T, et al. Atrophy of the cerebellum and brainstem in dentatorubral pallidoluysian atrophy. Influence of CAG repeat size on MRI findings. Neurology 1997;49:1605-12. (Pubitemid 28015125)
42. Akhlaghi H, Corben L, Georgiou-Karistianis N, et al. Superior cerebellar peduncle atrophy in Friedreich's ataxia correlates with disease symptoms. Cerebellum 2011;10:81-7.
43. Rizzo G, Tonon C, Valentino ML, et al. Brain diffusion-weighted imaging in Friedreich's ataxia. Mov Disord 2011;26:705-12.
44. Iltis I, Hutter D, Bushara KO, et al. (1)H MR spectroscopy in Friedreich's ataxia and ataxia with oculomotor apraxia type 2. Brain Res 2010;1358: 200-10.
45. McNeill A, Birchall D, Hayflick SJ, et al. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008;70:1614-19. (Pubitemid 351620317)
46. Walzer RH, Schulz VP, Tikhonova IR, et al. Genetic diagnosis of neuroacanthocytosis disorders using exome sequencing. Mov Disord 2012;27:539-43.
47. Evers MM, Pepers BA, van Deutekom JC, et al. Targeting several CAG expansion diseases by a single antisense oligonucleotide. PLoS One 2011;6: e24308.
48. Hartig MB, Prokisch H, Meitinger T, et al. Pantothenate kinase-associated neurodegeneration. Curr Drug Targets 2012;13:1182-9.
49. Edwards TC, Zrinzo L, Limousin P, et al. Deep brain stimulation in the treatment of chorea. Mov Disord 2012;27:357-63.